Advanced search
Publication Cover
Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration Volume 18, 2017 - Issue sup1: Edaravone (MCI-186) in Amyotrophic Lateral Sclerosis (ALS). Guest Editor: Angela Genge
Submit an article Journal homepage
6,680
Views
26
CrossRef citations to date
0
Altmetric
Review Article

An assessment of treatment guidelines, clinical practices, demographics, and progression of disease among patients with amyotrophic lateral sclerosis in Japan, the United States, and Europe

Koji TakeiMitsubishi Tanabe Pharma Development America Inc., Jersey City, NJ, USA and Correspondence[email protected]
,
Kikumi TsudaMitsubishi Tanabe Pharma Development America Inc., Jersey City, NJ, USA and
,
Fumihiro TakahashiMitsubishi Tanabe Pharma Corporation, Tokyo, Japan
,
Manabu HiraiMitsubishi Tanabe Pharma Corporation, Tokyo, Japan
&
Joseph PalumboMitsubishi Tanabe Pharma Development America Inc., Jersey City, NJ, USA and ;Mitsubishi Tanabe Pharma Corporation, Tokyo, Japan
Pages 88-97 | Received 26 Apr 2017, Accepted 26 Jul 2017, Published online: 05 Sep 2017

Reprints and Permissions

Permission is granted subject to the terms of the License under which the work was published. Permission will be required if your reuse is not covered by the terms of the License.

To request a reprint or commercial or derivative permissions for this article, please click on the relevant link below.

Order Reprints Request Permissions

For more information please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.